Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43698
Campo DC Valoridioma
dc.contributor.authorMartínez Quintana, Efrénen_US
dc.contributor.authorSaiz-Udaeta, Beatrizen_US
dc.contributor.authorMarrero-Negrin, Nataliaen_US
dc.contributor.authorLopez-Mérida, Xavieren_US
dc.contributor.authorRodriguez-Gonzalez, Faynaen_US
dc.contributor.authorNieto-Lago, Vicenteen_US
dc.date.accessioned2018-11-21T17:09:45Z-
dc.date.available2018-11-21T17:09:45Z-
dc.date.issued2013en_US
dc.identifier.issn1726-913Xen_US
dc.identifier.urihttp://hdl.handle.net/10553/43698-
dc.description.abstractIntroduction: Anabolic-androgenic steroids (AAS), a synthetic derivate of testosterone, have become a popular drug among athletes and bodybuilders to enhance muscle mass and improve the athletic performance. Many pathological effects such as hepatic and endocrine dysfunction, behavioural changes and cardiovascular complications have been reported. Case Report: Within these ast ones, we find an increase in left ventricular muscle mass, concentric myocardial hypertrophy, left ventricular diastolic dysfunction, arterial hypertension, prothrombotic effects, changes in the concentration of cholesterol levels, particularly a reduction in HDL cholesterol concentration, myocardial infarctions in relation to endothelial dysfunction, vasospasms or thrombosis and sudden cardiac death. Discussion: We report the case of a 32-year-old patient with a history of arterial hypertension, depressive syndrome and consumption of cocaine, amphetamines and AAS who developed severe left ventricular systolic dysfunction and myocardial hypertrophy with signs of heart failure and peripheral arterial embolism.en_US
dc.languageengen_US
dc.publisher1726-913X-
dc.relation.ispartofInternational Journal of Endocrinology and Metabolismen_US
dc.sourceInternational Journal of Endocrinology and Metabolism [ISSN 1726-913X], v. 11 (e8755)en_US
dc.subject320501 Cardiologíaen_US
dc.subject.otherAndrogenic Anabolic Steroiden_US
dc.subject.otherCocaineen_US
dc.subject.otherAmphetamineen_US
dc.subject.otherCardiacen_US
dc.subject.otherAdverse Effectsen_US
dc.subject.otherAbuseen_US
dc.titleAndrogenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effectsen_US
dc.typeinfo:eu-repo/semantics/articlees
dc.typeArticlees
dc.identifier.doi10.5812/ijem.8755en_US
dc.identifier.scopus84890097721-
dc.contributor.authorscopusid23485891800-
dc.contributor.authorscopusid55568384000-
dc.contributor.authorscopusid55960759800-
dc.contributor.authorscopusid55960892400-
dc.contributor.authorscopusid24825586600-
dc.contributor.authorscopusid8642874100-
dc.identifier.issuee8755-
dc.relation.volume11-
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.ulpgces
dc.description.esciESCI
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.fullNameMartínez Quintana, Efrén-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.